Baptiste Couvy-Duchesne

Baptiste Couvy-Duchesne

@baptistecd.bsky.social

Genetics, brain and more 🇦🇺🇫🇷 Working with the University of Queensland, Inria (France), Paris Brain Institute and QIMR Berghofer

233 followers584 following33 posts

Happy to share our latest paper, the work of @clarajiang.bsky.social who trained brain-based predictors of depression on the UK Biobank (N=7,500 curated cases and matched controls) using AI/deeplearning as well as efficient statistical learning (BLUP). See thread below for a summary of findings

nature.comApplying machine-learning and deep-learning to predict depression from brain MRI and identify depression-related brain biology - Translational PsychiatryTranslational Psychiatry - Applying machine-learning and deep-learning to predict depression from brain MRI and identify depression-related brain biology
View full thread

Happy to share our latest paper, the work of @clarajiang.bsky.social who trained brain-based predictors of depression on the UK Biobank (N=7,500 curated cases and matched controls) using AI/deeplearning as well as efficient statistical learning (BLUP). See thread below for a summary of findings

nature.comApplying machine-learning and deep-learning to predict depression from brain MRI and identify depression-related brain biology - Translational PsychiatryTranslational Psychiatry - Applying machine-learning and deep-learning to predict depression from brain MRI and identify depression-related brain biology
View full thread

In our article, we estimated the morphometricity of depression to be 6%, which means that only 6% of the disease status variance is captured by all brain measurements. This implies that an optimal linear predictor would only reach an AUC=0.64. See link for more on morphometricity (and BLUP)

onlinelibrary.wiley.comA unified framework for association and prediction from vertex‐wise grey‐matter structureThis manuscript introduces a set of analyses, that rely on linear mixed models to perform association and prediction, while being suited to tackle the challenges of big-data in neuroimaging. Our fram....

Happy to share our latest paper, the work of @clarajiang.bsky.social who trained brain-based predictors of depression on the UK Biobank (N=7,500 curated cases and matched controls) using AI/deeplearning as well as efficient statistical learning (BLUP). See thread below for a summary of findings

nature.comApplying machine-learning and deep-learning to predict depression from brain MRI and identify depression-related brain biology - Translational PsychiatryTranslational Psychiatry - Applying machine-learning and deep-learning to predict depression from brain MRI and identify depression-related brain biology
View full thread

Happy to share our latest paper, the work of @clarajiang.bsky.social who trained brain-based predictors of depression on the UK Biobank (N=7,500 curated cases and matched controls) using AI/deeplearning as well as efficient statistical learning (BLUP). See thread below for a summary of findings

nature.comApplying machine-learning and deep-learning to predict depression from brain MRI and identify depression-related brain biology - Translational PsychiatryTranslational Psychiatry - Applying machine-learning and deep-learning to predict depression from brain MRI and identify depression-related brain biology

I have always wondered if there is a best method/software to process T1w image (at a vertex/voxel wise level). Elise Delzant has some answers in her first published paper from her PhD. She compared FreeSurfer, CAT12 and FSL across several traits and analyses (association, prediction).

View full thread

Still, we hope our results can help researchers make informed decisions when selecting a processing. And that it can encourage others to evaluate other image processing options (e.g., different software versions, non-default settings).

I have always wondered if there is a best method/software to process T1w image (at a vertex/voxel wise level). Elise Delzant has some answers in her first published paper from her PhD. She compared FreeSurfer, CAT12 and FSL across several traits and analyses (association, prediction).

View full thread

To make things even more complicated, it may also depend on the trait you are interested in. On average FSL VBM does a good job, but for some traits like Alzheimer's disease or maternal smoking, FreeSurfer may yield more significant associations.

I have always wondered if there is a best method/software to process T1w image (at a vertex/voxel wise level). Elise Delzant has some answers in her first published paper from her PhD. She compared FreeSurfer, CAT12 and FSL across several traits and analyses (association, prediction).

View full thread

Elise's results also confirm that the choices of processing have important consequences on the results, which contributes to the reproducibility crisis. See results below for the same individuals and same trait (maternal smoking around birth - associated regions vary depending on processing)

I have always wondered if there is a best method/software to process T1w image (at a vertex/voxel wise level). Elise Delzant has some answers in her first published paper from her PhD. She compared FreeSurfer, CAT12 and FSL across several traits and analyses (association, prediction).

Lastly, we showed that the brain-based predictor of Alzheimer's could also predict early AD, mild cognitive impairment, cognition, tau levels or genetic risk. Our predictor is on par with some of the best ones that can predict progression to AD, which could help with early intervention

We have also estimated that there should be at least 5 times more regions that remain to be identified (difference between the morphometricity and variance currently explained by the identified regions). Even more data will be needed!

This is the largest study of its kind in terms of the number of participants (>9,000 subjects from 10 clinical cohorts+ the UK Biobank), and we have identified 103 grey matter regions associated with Alzheimer's, including some in ‘known’ regions, such as the hippocampus.

At this point, we do not know if the identified drugs or conditions directly cause neurodegenerative disorders or whether they are early symptoms of the disease or reflect more complex aetiology. However, the results could be useful for personalising and accelerating referrals to neurologists.

You are up to date.